Canaccord Genuity Group Cuts Privia Health Group (NASDAQ:PRVA) Price Target to $34.00

Privia Health Group (NASDAQ:PRVA) had its price objective dropped by equities research analysts at Canaccord Genuity Group from $35.00 to $34.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price would suggest a potential upside of 47.22% from the company’s current price.

Several other equities analysts have also recently issued reports on the company. Jefferies Financial Group reissued a “buy” rating and set a $32.00 target price on shares of Privia Health Group in a research note on Thursday, February 26th. Piper Sandler reissued an “overweight” rating and set a $36.00 target price on shares of Privia Health Group in a research note on Thursday, February 26th. Royal Bank Of Canada started coverage on Privia Health Group in a research note on Friday, January 9th. They set an “outperform” rating and a $31.00 target price on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Privia Health Group in a research report on Friday, March 27th. Finally, Citigroup dropped their price target on Privia Health Group from $34.00 to $32.00 and set a “buy” rating on the stock in a research report on Tuesday, March 3rd. Eleven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Privia Health Group has an average rating of “Moderate Buy” and an average price target of $31.23.

Privia Health Group Stock Down 3.7%

Shares of NASDAQ PRVA traded down $0.90 during trading hours on Friday, reaching $23.10. 1,080,445 shares of the stock traded hands, compared to its average volume of 870,132. The company has a market capitalization of $2.90 billion, a P/E ratio of 135.85, a price-to-earnings-growth ratio of 1.50 and a beta of 0.96. Privia Health Group has a 52-week low of $18.77 and a 52-week high of $26.51. The company’s 50-day simple moving average is $22.73 and its two-hundred day simple moving average is $23.34.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.11. The company had revenue of $603.85 million for the quarter, compared to analysts’ expectations of $560.99 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.Privia Health Group’s revenue for the quarter was up 25.8% compared to the same quarter last year. During the same period last year, the firm posted $0.22 EPS. As a group, sell-side analysts forecast that Privia Health Group will post 0.37 earnings per share for the current fiscal year.

Insider Transactions at Privia Health Group

In other news, CFO David Mountcastle sold 7,697 shares of the business’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $25.05, for a total value of $192,809.85. Following the completion of the transaction, the chief financial officer owned 172,909 shares in the company, valued at $4,331,370.45. The trade was a 4.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Parth Mehrotra sold 41,999 shares of the business’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $22.86, for a total value of $960,097.14. Following the completion of the transaction, the chief executive officer owned 343,795 shares of the company’s stock, valued at $7,859,153.70. This represents a 10.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 274,255 shares of company stock worth $6,299,092 over the last quarter. 5.70% of the stock is currently owned by insiders.

Institutional Trading of Privia Health Group

Hedge funds have recently bought and sold shares of the company. Bayban purchased a new stake in Privia Health Group during the fourth quarter valued at $26,000. Hantz Financial Services Inc. increased its position in Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after acquiring an additional 926 shares during the last quarter. Global Retirement Partners LLC increased its position in Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after acquiring an additional 1,351 shares during the last quarter. Canada Pension Plan Investment Board increased its position in Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after acquiring an additional 1,200 shares during the last quarter. Finally, Kestra Advisory Services LLC purchased a new stake in Privia Health Group during the fourth quarter valued at $93,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Trending Headlines about Privia Health Group

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Privia Health reported first-quarter results that beat revenue expectations, with sales of $603.85 million versus the $560.99 million estimate, and EPS of $0.19 versus $0.08 expected. The company also said revenue rose 25.8% year over year, and it reiterated full-year 2026 guidance. Article Title
• Positive Sentiment: The company’s updated 2026 outlook calls for revenue of $2.4 billion to $2.5 billion, which is in line with or slightly above market expectations and supports the case for continued growth. Article Title
• Neutral Sentiment: Investors are also parsing the Q1 2026 earnings call transcript and related earnings coverage for management commentary on margins, utilization trends, and the path to hitting full-year targets. Article Title
• Negative Sentiment: Two insider-selling reports may be weighing on sentiment: the CFO sold about $179,690 of stock and a director sold about $427,229 of stock, which can signal caution even when fundamentals are improving. Article Title Article Title

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.